- Home
- About
- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- IgAN
- Events
- Resource Center
- Rare Kidney Diseases (PKD, IgAN, & Others)
- Kidney Disease & Mental Health
- Kidney Disease & Comorbid Conditions
- Transplantation & Dialysis
- NephU Nutrition & The NephChefR
- Radiology Toolkit
- On Demand Webinars
- Infographics
- Podcasts
- Videos
- Request a Presentation
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Archives
Diabetic Kidney Disease: What Does It Mean For Patients?
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Diabetic Kidney Disease: What Does It Mean For Patients?
Background
Diabetes Mellitus (DM) frequently causes CKD and is called diabetic kidney disease (DKD).1 DKD progresses more rapidly with type 2 diabetes than type1.2 Every 24 hours, 170 patients with diabetes begin kidney replacement therapy.1
Did You Know?- One in three adults diagnosed with diabetes has chronic kidney disease.1
- During this webinar, Dr Lerma and Michael Filsinger will discuss an overview of diabetic kidney disease (DKD) and what it means for patients who have been diagnosed with DKD. They will explore the pathophysiology, risk factors, common tests and studies, as well as helpful recommendations and management options.
- Overview of DKD
- Modifiable and Non-Modifiable Risk Factors of DKD
- Routine Testing for DKD and CKD
- Medical Management and Recommendations for Treatment
- Diabetes and Chronic Kidney Disease. Centers for Disease Control and Prevention (CDC). https://www.cdc.gov/diabetes/managing/diabetes-kidney-disease.html Updated December 2022. Accessed January 2024.
- Diabetic Kidney Disease: Diagnosis, Treatment, and Prevention. American Family Physician. https://www.aafp.org/pubs/afp/issues/2019/0615/p751.html Published June 2019. Accessed January 2024.
Edgar Lerma, MD
Clinical Professor of Medicine, Section of Nephrology, University of Illinois at ChicagoUniversity of Illinois at Chicago*
Edgar Lerma, MD, earned his Doctor of Medicine from the University of Santo Tomas Faculty of Medicine and Surgery in Manila, Philippines. He completed Residency Training in Internal Medicine at UIC/Mercy Hospital and Medical Center, where he also served as Chief Resident. He completed a Fellowship in Nephrology and Hypertension at Northwestern Memorial Hospital, the Feinberg School of Medicine at Northwestern University, and the Veterans Administration Lakeside Medical Center in Chicago, Illinois.
Dr Lerma is a Diplomate in the Subspecialty of Nephrology with the American Board of Internal Medicine. He has authored more than 100 peer-reviewed publications and presentations; notable publications include Current Diagnosis & Treatment: Nephrology & Hypertension, Nephrology Secrets, and Henrich’s Principles and Practice of Dialysis. He has peer reviewed and served on editorial boards for numerous journals, and currently is Associate Editor for International Urology and Nephrology, Clinical Reviews in Bone and Mineral Metabolism, and Journal of Clinical Lipidology.
At present, he holds the rank of Clinical Professor of Medicine with the Section of Nephrology at University of Illinois at Chicago. He serves as the Educational Coordinator for Nephrology with UIC/Advocate Christ Medical Center.
In recognition of his clinical work and expertise, Dr Lerma has been elected to Fellowship of the American College of Physicians, Fellowship of the American Society of Nephrology, Fellowship of the American Heart Association/ Council on Kidney in Cardiovascular Disease, Fellowship of the American Society of Hypertension, Fellowship of the National Lipid Association, Fellowship of the National Kidney Foundation, and Fellowship of the American Society of Diagnostic and Interventional Nephrology. He has also been recognized for teaching and has been the recipient of “Subspecialty Teaching Attending Physician of the Year” in 2006 and “Physician Recognition Award for Excellence in Academics” in 2011 from UIC/Advocate Christ Medical Center Internal Medicine Residency Training Program.
Dr Lerma’s research interests include CKD, hypertension, bone and mineral disorders, and dyslipidemias in CKD.
Michael Filsinger, MPA, PA-C
Nephrology Medical Science LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Michael Filsinger, MPA, PA-C is a Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Michael earned his Bachelor of Health Care Sciences as well as Master of Physician Assistant at Duquesne University in Pittsburgh, PA. Following his graduate training, Michael went on to complete a Pediatric Surgery Residency at Children’s National Medical Center in Washington, DC Prior to joining Otsuka, Michael spent the last 15 years working in solid organ transplant in Charlotte, NC where he developed a passion for improving the care of patients with renal disease and ESKD.
*Dr Edgar Lerma is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Michael Filsinger is an employee of OPDC.
Registration
Related Resources
-
On-Demand Webinar: The Four-Hit Hypothesis & The Role Of APRIL In IgA Nephropathy
On-Demand Webinar December 20, 2024The goal of this on-demand webinar is to provide a detailed overview of the Four-Hit hypothesis as well as explain the role of APRIL in disease pathogenesis.
-
Hot Topics in Nephrology: First Year Results from the Centers for Medicare & Medicaid Services Kidney Care Choices Model
Audio/Podcast December 11, 2024The Kidney Care Choices (KCC) Model is designed to bring groups of nephrologists and other kidney care providers together to take responsibility for patients who have late-stage chronic kidney disease,…
-
Kidney Disease in Native Americans & Alaskan Natives
On-Demand Webinar November 22, 2024This webinar discussion featuring Dr. Ashar Luqman will discuss the prevalence of various common and rare kidney diseases and comorbidities among the Native American population.
Related Events
-
Cooking Demo: Dietary Considerations for Patients with IgA Nephropathy
March 12, 2025 from 12:00 pm to 1:00 pm
Join Today for Instant Access to all NephU Offerings.
Membership is free!
Join NephU today at no cost to register for this event and access to other premium content.
- The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
- Quickly learn more about the topics that interest you.
- Access our library of on-demand kidney health resources
- Gain key insights from industry experts & though leaders.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.